Browsing by Author "Titus, Richard G"
Now showing items 1-8 of 8
-
Development of a safe live Leishmania vaccine line by gene replacement.
Titus, Richard G et al. | Date Issued: 1995 -
Indomethacin treatment slows disease progression and enhances a Th1 response in susceptible BALB/c mice infected with Leishmania major.
Freitas, Luiz Antonio Rodrigues de et al. | Date Issued: 1999 -
Interleukin-6 deficiency influences cytokine expression in susceptible BALB mice infected with Leishmania major but does not alter the outcome of disease.
Titus, Richard G et al. | Date Issued: 2001 -
Short report: requirement of b cells for delayed type hypersensitivity-like pathology after secondary infection with Leishmania major in resistant C57BL/6 mice
Dekrey, Gregory K et al. | Date Issued: 2003 -
The Vasoactive Peptide Maxadilan from Sand Fly Saliva Inhibits TNF-! and Induces IL-6 by Mouse Macrophages Through Interaction with the Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Receptor
Soares, Milena Botelho Pereira et al. | Date Issued: 1998 -
Type 1 and type 2 responses to Leishmania major
Rogers, Kathleen A et al. | Date Issued: 2002 -
Variation in the salivary peptide, maxadilan, from species in the Lutzomyia longipalpis complex.
Lanzaro, G. C et al. | Date Issued: 1999 -
Virulent or avirulent (dhfr-ts-) Leishmania major elicit predominantly a type-1 cytokine response by human cells in vitro
Brodskyn, Claudia Ida et al. | Date Issued: 2000